[1] | Haipeng WANG, Yi LIU, Donghui LI, Guanghui SHEN. Expression of interleukin-33 in hepatocellular carcinoma patients and its role in regulating CD8+ T cell function[J]. Journal of Clinical Hepatology, 2022, 38(1): 117-123. doi: 10.3969/j.issn.1001-5256.2022.01.018 |
[2] | Xu WANG, Shanshan XU, Yihui RONG, Huanjing CAI, Guiqiang WANG. Rate of active immune response to hepatitis B vaccine in adult hepatitis B recipients after liver transplantation and its correlation with CD4 level before vaccination[J]. Journal of Clinical Hepatology, 2021, 37(8): 1802-1805. doi: 10.3969/j.issn.1001-5256.2021.08.012 |
[3] | Gao MengDan, Tan Ling, Sun JianPing, Li Kang, Li Ang, Lou JinLi, Zhang YongHong, Zhao Yan. Expression and significance of T-cell immunoglobulin and mucin domain-containing molecule 3 in peripheral blood CD3+CD56+ natural killer T cells in patients with hepatitis B virus-related acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2019, 35(9): 2006-2010. doi: 10.3969/j.issn.1001-5256.2019.09.024 |
[4] | Wang HaiYan, Zhu Li, Wang YinLing, Zhu YuePing, Zhu XiaoYan, Chai XiaoZhe, Qian Feng, Li Ming, Zhu ChuanWu. Impact of pegylated interferon versus conventional interferon on the change in peripheral CD4+CD25highT cells in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2018, 34(1): 53-57. doi: 10.3969/j.issn.1001-5256.2018.01.011 |
[5] | Li Yu, Tian Ying, Yang XiaoMei, Cao NingJia, Li Zhu, Zhang Hong, Zhang XianJiao. Effect of thymosin α1 on the function of CD4+CD25+CD127dim/- regulatory T cells in chronic hepatitis B patients[J]. Journal of Clinical Hepatology, 2018, 34(5): 1011-1014. doi: 10.3969/j.issn.1001-5256.2018.05.017 |
[6] | Wang Wei, Zhao RongRong, Yang XiaoFei, Huang ZhangXing, Lian JianQi, Wang JiuPing, Zhang Ye. Influence of Notch signaling pathway on interleukin-22 secreted by CD4~+T cells in patients with hepatitis B[J]. Journal of Clinical Hepatology, 2016, 32(7): 1315-1318. doi: 10.3969/j.issn.1001-5256.2016.07.020 |
[7] | Guo FeiBo. Change in peripheral blood CD4~+ regulatory T cells and its association with antiviral effect in patients with chronic hepatitis C[J]. Journal of Clinical Hepatology, 2016, 32(12): 2317-2321. doi: 10.3969/j.issn.1001-5256.2016.12.017 |
[8] | Dong Jie, Yang XiaoFei, Shen HuanJun, Zhao RongRong, Zhao YanYan, Zhang Ye, Huang ZhangXing, Lian JianQi. Regulatory effect of gamma-chain cytokines on expression of TIM-3 on CD8~+T cells in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2015, 31(2): 205-208. doi: 10.3969/j.issn.1001-5256.2015.02.015 |
[9] | Xian YongChao, Cheng ShuQuan, Ni Hui, Huang ChengJun. Analysis of hepatic CD4~+,CD8~+,CD20~+,and CD57~+ T lymphocytes in chronic hepatitis B patients with different HBe Ag status[J]. Journal of Clinical Hepatology, 2015, 31(4): 546-550. doi: 10.3969/j.issn.1001-5256.2015.04.017 |
[10] | Li CaiDong, Chen XiLian, Tian PengFei, Li HuiJun, Wu Bin. Correlation analysis of percentages of T lymphocyte subsets and CD4~+CD25~+ regulatory T cells and HBV DNA level in peripheral blood of chronic hepatitis B patients[J]. Journal of Clinical Hepatology, 2015, 31(4): 541-545. doi: 10.3969/j.issn.1001-5256.2015.04.016 |
[11] | Shi QingFeng, Zhang YingXin, Song JiKui, Yuan JianGuo, Li QingFang, Zhao HongKui, Ceng WeiQun, Chen Min. Effect of prostaglandin E1 on the dendritic cells maturation and the activity of CD4+/CD8+ T cells in chronic severe hepatitis B patients[J]. Journal of Clinical Hepatology, 2012, 28(3): 212-215. |
[12] | Zhao DanTong, Yan HuiPing, Liao HuiYu, Liu YanMin, Feng Xia, Zhao Yan, Liu XiuHong, Kong XiangSha. Expression of Toll like receptors on peripheral blood mononuclear cells and their influence on CD4+CD25+T regula- tory cells in patients with primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2012, 28(1): 58-62. |
[13] | Li YanLi, Zhao Yan, Yan HuiPing. Evolution of regulatory T cells in pathogenesis of autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2012, 28(5): 332-334. |
[14] | Jiang ShuLian, Tan ShanZhong, Wen Jian. Role of CD4+CD25+ T regulatory cells in HBeAg seroconversion during interferon antiviral[J]. Journal of Clinical Hepatology, 2012, 28(7): 528-530. |
[15] | Wu YinYa, Tan ShanZhong, Zhao Lei, Sun WeiWei, Shen JianJun, Liang ZhongFeng. The changes and value of the proportion of CD4+CD25+ regulatory T cells in HBeAg (+) and HBeAg (-) ASC in peripheral blood[J]. Journal of Clinical Hepatology, 2012, 28(3): 209-211. |
[16] | Shi QingFeng, Song JiKui, Zhang YingXin, Yuan JianGuo, Wang SiKui, Li QingFang, Zhao HongKui. Study on the expression of HLA-DR/CD69 on CD4+/CD8+T cells in the treatment of HBeAg-positive chronic hepatitis B with interferon alfa-2b[J]. Journal of Clinical Hepatology, 2011, 27(12): 1285-1287+1300. |
[18] | Chou JiaoMin, Han Ying, Ji YunXia, Dong PeiLing, Shang HongWei, Wang XingCui, Zhang Bin, Ding HuiGuo. Relationship between CD4+CD25+ regulatory T cells and exacerbation of liver disease related HBV mutation patients[J]. Journal of Clinical Hepatology, 2008, 24(6): 419-422. |
[19] | Chen Zhong, Ni JiaLian, Liu LuYue, Yan JianJun, Huang Liang, Yan YiQun. The relationship between CD4+CD25+ regulatory T Cells and T lymphocytes immunity in tumor microenvironment of hepatocellular carcinoma.[J]. Journal of Clinical Hepatology, 2008, 24(1): 38-40. |